Cargando…

Differences of molecular events driving pathological and radiological progression of lung adenocarcinoma

BACKGROUND: Ground-glass opacity (GGO)-like lung adenocarcinoma (LUAD) has been detected increasingly in the clinic and its inert property and superior survival indicate unique biological characteristics. However, we do not know much about them, which hampers identification of key reasons for the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Jun, Jiang, He, Zhao, Yue, Lai, Jinglei, Shi, Leming, Yang, Jingcheng, Chen, Haiquan, Zheng, Yuanting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406962/
https://www.ncbi.nlm.nih.gov/pubmed/37506543
http://dx.doi.org/10.1016/j.ebiom.2023.104728
_version_ 1785085854272716800
author Shang, Jun
Jiang, He
Zhao, Yue
Lai, Jinglei
Shi, Leming
Yang, Jingcheng
Chen, Haiquan
Zheng, Yuanting
author_facet Shang, Jun
Jiang, He
Zhao, Yue
Lai, Jinglei
Shi, Leming
Yang, Jingcheng
Chen, Haiquan
Zheng, Yuanting
author_sort Shang, Jun
collection PubMed
description BACKGROUND: Ground-glass opacity (GGO)-like lung adenocarcinoma (LUAD) has been detected increasingly in the clinic and its inert property and superior survival indicate unique biological characteristics. However, we do not know much about them, which hampers identification of key reasons for the inert property of GGO-like LUAD. METHODS: Using whole-exome sequencing and RNA sequencing, taking into account both radiological and pathological classifications of the same 197 patients concomitantly, we systematically interrogate genes driving the progression from GGO to solid nodule and potential reasons for the inertia of GGO. Using flow cytometry and IHC, we validated the abundance of immune cells and activity of cell proliferation. FINDINGS: Identifying the differences between GGO and solid nodule, we found adenocarcinoma in situ/minimally invasive adenocarcinoma (AIS/MIA) and GGO-like LUAD exhibited lower TP53 mutation frequency and less active cell proliferation-related pathways than solid nodule in LUAD. Identifying the differences in GGO between AIS/MIA and LUAD, we noticed that EGFR mutation frequency and CNV load were significantly higher in LUAD than in AIS/MIA. Regulatory T cell was also higher in LUAD, while CD8+ T cell decreased from AIS/MIA to LUAD. Finally, we constructed a transcriptomic signature to quantify the development from GGO to solid nodule, which was an independent predictor of patients’ prognosis in 11 external LUAD datasets. INTERPRETATION: Our results provide deeper insights into the indolent nature of GGO and provide a molecular basis for the treatment of GGO-like LUAD. FUNDING: This study was supported in part by the 10.13039/501100001809National Natural Science Foundation of China (32170657), the 10.13039/501100001809National Natural Science Foundation of China (82203037), and Shanghai Sailing Program (22YF1408900).
format Online
Article
Text
id pubmed-10406962
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104069622023-08-09 Differences of molecular events driving pathological and radiological progression of lung adenocarcinoma Shang, Jun Jiang, He Zhao, Yue Lai, Jinglei Shi, Leming Yang, Jingcheng Chen, Haiquan Zheng, Yuanting eBioMedicine Articles BACKGROUND: Ground-glass opacity (GGO)-like lung adenocarcinoma (LUAD) has been detected increasingly in the clinic and its inert property and superior survival indicate unique biological characteristics. However, we do not know much about them, which hampers identification of key reasons for the inert property of GGO-like LUAD. METHODS: Using whole-exome sequencing and RNA sequencing, taking into account both radiological and pathological classifications of the same 197 patients concomitantly, we systematically interrogate genes driving the progression from GGO to solid nodule and potential reasons for the inertia of GGO. Using flow cytometry and IHC, we validated the abundance of immune cells and activity of cell proliferation. FINDINGS: Identifying the differences between GGO and solid nodule, we found adenocarcinoma in situ/minimally invasive adenocarcinoma (AIS/MIA) and GGO-like LUAD exhibited lower TP53 mutation frequency and less active cell proliferation-related pathways than solid nodule in LUAD. Identifying the differences in GGO between AIS/MIA and LUAD, we noticed that EGFR mutation frequency and CNV load were significantly higher in LUAD than in AIS/MIA. Regulatory T cell was also higher in LUAD, while CD8+ T cell decreased from AIS/MIA to LUAD. Finally, we constructed a transcriptomic signature to quantify the development from GGO to solid nodule, which was an independent predictor of patients’ prognosis in 11 external LUAD datasets. INTERPRETATION: Our results provide deeper insights into the indolent nature of GGO and provide a molecular basis for the treatment of GGO-like LUAD. FUNDING: This study was supported in part by the 10.13039/501100001809National Natural Science Foundation of China (32170657), the 10.13039/501100001809National Natural Science Foundation of China (82203037), and Shanghai Sailing Program (22YF1408900). Elsevier 2023-07-26 /pmc/articles/PMC10406962/ /pubmed/37506543 http://dx.doi.org/10.1016/j.ebiom.2023.104728 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Shang, Jun
Jiang, He
Zhao, Yue
Lai, Jinglei
Shi, Leming
Yang, Jingcheng
Chen, Haiquan
Zheng, Yuanting
Differences of molecular events driving pathological and radiological progression of lung adenocarcinoma
title Differences of molecular events driving pathological and radiological progression of lung adenocarcinoma
title_full Differences of molecular events driving pathological and radiological progression of lung adenocarcinoma
title_fullStr Differences of molecular events driving pathological and radiological progression of lung adenocarcinoma
title_full_unstemmed Differences of molecular events driving pathological and radiological progression of lung adenocarcinoma
title_short Differences of molecular events driving pathological and radiological progression of lung adenocarcinoma
title_sort differences of molecular events driving pathological and radiological progression of lung adenocarcinoma
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406962/
https://www.ncbi.nlm.nih.gov/pubmed/37506543
http://dx.doi.org/10.1016/j.ebiom.2023.104728
work_keys_str_mv AT shangjun differencesofmoleculareventsdrivingpathologicalandradiologicalprogressionoflungadenocarcinoma
AT jianghe differencesofmoleculareventsdrivingpathologicalandradiologicalprogressionoflungadenocarcinoma
AT zhaoyue differencesofmoleculareventsdrivingpathologicalandradiologicalprogressionoflungadenocarcinoma
AT laijinglei differencesofmoleculareventsdrivingpathologicalandradiologicalprogressionoflungadenocarcinoma
AT shileming differencesofmoleculareventsdrivingpathologicalandradiologicalprogressionoflungadenocarcinoma
AT yangjingcheng differencesofmoleculareventsdrivingpathologicalandradiologicalprogressionoflungadenocarcinoma
AT chenhaiquan differencesofmoleculareventsdrivingpathologicalandradiologicalprogressionoflungadenocarcinoma
AT zhengyuanting differencesofmoleculareventsdrivingpathologicalandradiologicalprogressionoflungadenocarcinoma